Pk Med

Biotechnology Research • 14, Rue Jean-Antoine de Baïf, France • 11-20 Employees

Company overview

Headquarters	14, Rue Jean-Antoine de Baïf, Paris, Île-de-France 75013, FR
Website	pk-med.com
Keywords	Biotechnology, Biomaterials, Pharmaceuticals, Innovation, Drug Delivery, Biotech, Drug Repurposing, Sustained Release, Drug Reformulation
Founded	2019
Employees	11-20
Socials

Key Contact at Pk Med

Gauthier Pouliquen

Chief Executive Officer

Pk Med Email Formats

Pk Med uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@pk-med.com), used 50% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@pk-med.com	50%
{first name}.{last name}	john.doe@pk-med.com	50%

About Pk Med

PK MED is a pioneering French biotech company, privately owned and founded in 2019 in Lyon, France, with the backing of Truffle Capital, a leading European venture capital firm specializing in life sciences. Built around a dedicated team of passionate and seasoned experts in pharmaceutical sciences, drug delivery, and biomaterials design, PK MED combines innovation and expertise to develop cutting-edge solutions in healthcare. PK MED specializes in the development of innovative, custom-designed, injectable, and biodegradable micro-implants, leveraging its expertise to address critical healthcare challenges. Our focus lies in advanced drug delivery systems for rheumatology and pioneering cell-homing techniques to enhance the success of bone marrow transplantation. Driven by a commitment to unmet medical needs, PK MED has built a promising portfolio of early-stage projects targeting key therapeutic areas, including gout flares, osteoarthritis, and hemoglobinopathies

Pk Med revenue & valuation

Annual revenue	$941,105
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,100,000
Total funding	$1,600,000